Suppr超能文献

在多细胞尺度上,将BED和EUD概念用于非均匀放射性分布的靶向放射性核素治疗。

The use of BED and EUD concepts in heterogeneous radioactivity distributions on a multicellular scale for targeted radionuclide therapy.

作者信息

Kalogianni Eleni, Flux Glenn D, Malaroda Alessandra

机构信息

Department of Medical Physics, Royal Free Hampstead NHS Trust, London, UK.

出版信息

Cancer Biother Radiopharm. 2007 Feb;22(1):143-50. doi: 10.1089/cbr.2007.308.

Abstract

There is evidence that nonuniform activity distributions within tumors might cause targeted radionuclide therapy (TRT) to fail. The aim of this study was to investigate the effects of the temporal and spatial behavior of the radioactivity in TRT, focusing on heterogeneous radiopharmaceutical distributions at a multicellular scale. Various activity distributions at the multicellular level from three radionuclides ((32)P, (90)Y, and (131)I) were simulated in cubic matrices (1- and 3-mm side). The in-house software package DOVE was used to calculate dose-rate maps, and survival fractions were calculated taking into account an up-take and a clearance phase. The effect from nonuniform activity distributions was analyzed in terms of dose volume histograms (DVHs), biologically effective dose (BED), and the effective uniform dose (EUD). The fraction of the absorbed dose that is "wasted," without producing a biological effect to the treatment, reaches 60% in the highly nonuniform distributions. For (32)P and (90)Y, the loss of therapeutic effectiveness was shown to be less than for (131)I. However, (90)Y, owing to its shorter physical half-life, presented lower mean BED values in almost every geometry, compared to (32)P and (131)I, and thus was less effective. (131)I, among all geometries, appeared to be more effective in more homogeneous activity distributions and in the 1-mm volume of interest, whereas it was the least effective radionuclide in the more heterogeneous activity distributions. (32)P presented the highest values of EUD, compared to (90)Y and (131)I. The EUD is a unique value that facilitates comparisons between different activity distributions in terms of treatment outcome. This study showed that as the degree of the heterogeneity in the dose distributions increases, the therapy effectiveness worsens. Nonuniform absorbed dose distributions can create a situation in which a fraction of cells are underirradiated, while another fraction of cells is "over-killed."

摘要

有证据表明,肿瘤内放射性活度分布不均可能导致靶向放射性核素治疗(TRT)失败。本研究的目的是调查TRT中放射性活度的时间和空间行为的影响,重点关注多细胞尺度上放射性药物的不均匀分布。在边长为1毫米和3毫米的立方矩阵中模拟了三种放射性核素(³²P、⁹⁰Y和¹³¹I)在多细胞水平的各种活度分布。使用内部软件包DOVE计算剂量率图,并在考虑摄取和清除阶段的情况下计算存活分数。根据剂量体积直方图(DVH)、生物等效剂量(BED)和有效均匀剂量(EUD)分析了不均匀活度分布的影响。在高度不均匀分布中,未对治疗产生生物学效应的“浪费”吸收剂量分数达到60%。对于³²P和⁹⁰Y,治疗效果的损失显示小于¹³¹I。然而,由于⁹⁰Y的物理半衰期较短,与³²P和¹³¹I相比,几乎在每种几何形状中其平均BED值都较低,因此效果较差。在所有几何形状中,¹³¹I在更均匀的活度分布和1毫米感兴趣体积中似乎更有效,而在更不均匀的活度分布中它是效果最差的放射性核素。与⁹⁰Y和¹³¹I相比,³²P的EUD值最高。EUD是一个独特的值,有助于根据治疗结果比较不同的活度分布。这项研究表明,随着剂量分布不均匀程度的增加,治疗效果会恶化。不均匀的吸收剂量分布可能会导致一部分细胞照射不足,而另一部分细胞则“过度杀伤”的情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验